Clarivate Enhances Access to Key Regulatory Intelligence via Claude Integration

Clarivate Enhances Regulatory Intelligence with Claude

In a bold move to improve the accessibility of regulatory data, Clarivate Plc, a premier global provider of transformative intelligence, recently announced its plans to integrate proprietary regulatory insights with Claude's artificial intelligence capabilities. This collaboration aims to equip professionals in biopharma, biotech, medtech, and clinical research sectors with intelligent, context-aware access to essential regulatory information, enhancing their existing AI workflows.

The partnership involves the integration of Cortellis Regulatory Intelligence (CRI) data with Claude's AI reasoning technology via the open Model Context Protocol (MCP). This connection allows Clarivate's authoritative regulatory data to be embedded directly into customer workflows. By combining the natural language understanding and reasoning capabilities of Claude with Clarivate’s industry-validated sources, users will receive accurate, referenced answers. This aims to facilitate more rapid and confident regulatory decision-making.

The new CRI MCP offers regulatory affairs, pharmacovigilance, and life sciences teams streamlined access to Clarivate's regulatory intelligence. It provides answers that are not only accurate and referenced but founded on reliable industry sources. Customers of both Clarivate's CRI and Claude will benefit from this integration, which is already set to make significant changes to their operational frameworks.

Henry Levy, President of Life Sciences & Healthcare at Clarivate, emphasized the importance of this advancement, stating that it supports their strategy to extend Clarivate intelligence into AI ecosystems critical for decision-making. “Bringing Cortellis Regulatory Intelligence into Claude expands the reach of our trusted regulatory insights. This enables our life sciences customers to access authoritative content directly within their existing AI workflows, allowing them to make better-informed decisions that help deliver safer and more effective therapies to patients,” he explained.

The integration builds upon the recent introduction of the CRI AI Assistant, furthering anticipatory intelligence and intelligent automation across regulatory workflows. By enabling organizations to combine CRI data with internal data and other authorized external sources, Clarivate is paving the way for a more comprehensive regulatory intelligence approach. This integration not only supports the monitoring of changes but also enhances decision-making capabilities by ensuring that customers have access to the most timely and relevant information.

Overall, this partnership represents a significant step forward for organizations that rely heavily on regulatory insights infused within their technology ecosystems. By enhancing the accessibility and usability of this vital regulatory data, Clarivate is positioning itself as an indispensable player in the life sciences field and beyond. As they continue to integrate more intelligence into AI environments, the future looks promising for professionals who rely on informed decision-making in their critical work.

For more information about Cortellis Regulatory Intelligence and its features, visit Cortellis Regulatory Intelligence.

About Clarivate

Clarivate is a leading global provider of transformative intelligence, delivering enriched data, insights, analytics, workflow solutions, and expert services across various sectors, including Academia, Government, Intellectual Property, and Life Sciences & Healthcare.